ENTROPY NEURODYNAMICS LIMITED — Director's Dealing 2024

Nov 7, 2024

Appendix 3X Initial Director's Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity	Tryptamine Therapeutics Limited
ABN	78 163 765 991

We (the entity) give ASX the following information under listing rule 3.19.A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Daniel Tillett
Date of appointment	08 November 2024

Part 1 - Director's relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Number & class of securities

12,000,000 - ORDINARY FULLY PAID SHARES

Part 2 - Director's relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature ofinterestNote: Provide details of the circumstancesgiving rise to the relevant interest.N/A	Number & class of SecuritiesN/A

Part 3 - Director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Subscriber, subject to shareholder approval, in the twotranche capital raising.
Nature of interest	Subscriber, subject to shareholder approval, in the twotranche capital raising as announced by TYP on 30October 2024. The EGM and Placement, subject toshareholder approval, are expected to occur in January2025.

• See chapter 19 for defined terms.

11/03/2002

Appendix 3X Page 1

Appendix 3X Initial Director's Interest Notice

Name of registered holder (ifissued securities)	Daniel Tillett
No. and class of securities towhich interest relates	50,000,000 - ORDINARY FULLY PAID SHARES25,000,000 - UNLISTED OPTIONS EXERCISABLE AT$0.04 AND EXPIRING 2 YEARS FROM THE DATE OFISSUE

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/03/2002